Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Two randomized trials reported significant improvements in FEV 1 and FVC with NAC (200 mg TID or 400 mg BID) in CF patients, with or without P
India became one of the first major markets to see generic launches after Novo Nordisks core patent on the molecule expired there in March 2026
No interest when you pay on time
This signal is crucial for maintaining and improving brain function, especially in conditions where neuronal loss or damage is prevalent
Deletion of YTHDF1 significantly increased lipid ROS generation (Fig
US$ 26.08
US$ 23.74
US$ 22.22
